Nifty Pharma Index Drops 2.52% Following Trump’s Tariff Proposal on Drug Imports
Stocks in the Nifty Pharma index were down by as much as 10% following US President Donald Trump's proposal to impose tariffs; Here's what you should know
You may also like
